EMVO Calls For Enforcement Of FMD/DR
Start enforcing the FMD or risk a total collapse.
Start enforcing the FMD or risk a total collapse.
The EC finally recognized the need for aggregation data to meet the FMD. They suggested short-term and a long-term solutions.
IQPC interviews pharma supply chain industry veteran, Kevan MacKenzie of McKesson.
Two new DSCSA-related documents from the HDA and C4SCS.
Nine years of RxTrace. A year in review, and looking forward.
Which DSCSA requirements are the most helpful for increasing patient safety? You might be surprised.
The second FDA DSCSA public meeting showed why the DSCSA 2023 deadline will not be met.
There is a reason so many RxTrace essays have something to do with the Healthcare Distribution Alliance (HDA) (I won’t list them all, but here are two recent ones: “HDA Traceability Seminar: RxTrace Future Topic List Explodes” and “HDA Schools FDA On DSCSA”). It’s because they have their fingers in just about everything related to … Continue reading HDA’s 2017 Manufacturer Serialization Readiness Survey Results
DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of RxTrace. The material contained in RxTrace is not legal advice. The writers of RxTrace are not lawyers.
The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel
and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating
the positions of any company, organization or individual other than RxTrace.
RxTrace, a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance.
Contact Us | Privacy Statement
Copyright © 2009-2021 TrackTraceRx, Inc. All Rights Reserved.
RxTrace is a registered trademark of TrackTraceRx, Inc